Servier and MiNA Therapeutics sign €220m deal

Retrieved on: 2021-01-21 18:43:51

Tags for this article:

Click the tags to see associated articles and topics

Servier and MiNA Therapeutics sign €220m deal. View article details on hiswai:

Excerpt

The collaboration is an extension to MiNA Therapeutics' R&D activities that has been so far focussed on liver cancer. Share European Biotechnology ...

Article found on: european-biotechnology.com

View Original Article